NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002012

Registered date:30/04/2010

Evaluation of pegaptanib and ranibizumab for macular edema secondary to retinal vein occlusion

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedmacular edema secondary to retinal vein occlusion
Date of first enrollment2009/04/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Intravitreal pegaptanib for treatment Intravitreal ranibizumab for treatment

Outcome(s)

Primary Outcomevisual acuity,foveal thickness
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum90years-old
GenderMale and Female
Include criteria
Exclude criteriaThe patients with good visual acuity

Related Information

Contact

public contact
Name
Address 2-2-2iidanishi,Yamagata city Japan
Telephone 023-628-5374
E-mail
Affiliation Yamagata university,Faculty of Medicine Department of Ophthalmology
scientific contact
Name Hidetoshi Yamashita
Address 2-2-2iidanishi,Yamagata city Japan
Telephone 023-628-5374
E-mail
Affiliation Yamagata university,Faculty of Medicine Department of Ophthalmology